Synergism between interferon-alpha and carboplatin in inhibiting K562 human myeloid leukaemia clonogenic cells: new potential therapeutic development. [electronic resource]
- Leukemia research 1992
- 419-20 p. digital
Publication Type: Letter; Research Support, Non-U.S. Gov't